The U.S. manufacturing sector contracted for the fifth straight month in December, with the monthly reading from the Institute for Supply Management (ISM) hitting its weakest point in more than 10 years. The purchasing manager’s index (PMI) fell to 47.2,...
Frank Holmes
|
January 8, 2020
|
Earnings reports are useful for measuring financial milestones, but they don’t tell the whole story. Siyata Mobile (NASDAQ: SYTA, SYTAW) released their Q2 earnings on an October 15th call that included CEO Marc Seelenfreund, VP of Corporate Development Daniel...
Featured Submission
|
October 27, 2021
|
Canopy Growth Corp. (TSX:WEED) holds a prominent position in the Canadian cannabis industry, but is it a good stock to buy? Initially, the stock experienced remarkable growth, driven by the anticipation surrounding the legalization of recreational cannabis in ...
Jonathon Brown
|
December 13, 2023
|
Shares of Avid Bioservices traded higher today, reaching a new 52-week high, after the firm reported Q2/20 earnings and reaffirmed its revenue guidance for Full-Year 2020. After the U.S. financial markets closed yesterday, biologics contract development and manufactur...
Streetwise Reports
|
December 11, 2019
|
After a century of cannabis prohibition, it should not come as any surprise that the normalization of cannabis laws in North America (and around the world) has been a slow, uneven process. Despite how clumsy and inefficient North American governments have been in executin...
Stockhouse Editorial
|
April 6, 2022
|
The following is a transcription of the above video, and The Market Online Canada has edited it for clarity . Our next company is Visionstate Corp. (TSXV:VIS) , headquartered in Edmonton. The company is focused on delivering data-driven, innovative and sustainable ...
Ryan Dhillon
|
February 14, 2024
|
XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis
|
May 10, 2021
|
Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...
Streetwise Reports
|
December 27, 2019
|
We continue to cover the copper story by looking at the supply and demand cycle, the EV movement, and the details behind the copper squeeze. World Copper Ltd. (TSXV:WCU) CEO Nolan Peterson, joins The Market Herald Canada’s Coreena Robertson on the Expert...
Coreena Robertson
|
August 14, 2023
|
Oh, the law of unintended consequences and the opportunities it brings. Thanks to the new standard of Keynesian Abenomics, the Nikkei has blasted 47% higher since November. The Yen has lost about 25% against the U.S. dollar in the same time. While we don't know what the ...
Peter Krauth
|
June 13, 2013
|